The all-GaN 10 kW 800 V–to–50 V DC-DC platform employs advanced 650 V and 100 V GaNFast FETs in a three-level half-bridge architecture with synchronous rectification to deliver 98.5% peak efficiency ...

Navitas Semiconductor launches world's first 650 V bi-directional GaNFast ICs, enabling efficient single-stage power converters for diverse applications. Navitas Semiconductor has announced a ...

TORRANCE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Navitas Semiconductor, (Nasdaq: NVTS) today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February ...

Navitas is down -74% from its IPO price in late 2021, despite GaN chip technology that is gaining traction in a variety of digital-to-power applications. Smart phone, AI datacenter, EV auto, and solar ...

Navitas Semiconductor NVTS shares have dropped 18.3% in a month, underperforming the Zacks Computer and Technology sector’s return of 3%. The underperformance can be attributed to sluggish ...

Navitas Credit, a wholly owned subsidiary of United Community, engaged in a comprehensive transformation of its digital footprint with the launch ...

Navitas has positioned itself for growth in the power chip market, particularly in electric vehicles and mobile devices. Navitas has found a niche, solidifying its role as a developer of chips ...

Navitas Semiconductor will report Q1 2025 financial results on May 5, with a conference call at 2:00 PM Pacific. Navitas Semiconductor, a next-generation power-semiconductor company, announced that it ...

GaN expected production ramp in new mainstream markets in AI data centers, solar micro-inverters and EV over next 12 months GaN sets industry benchmark with over 250M shipped and 100ppb field ...

This former penny stock is up 78% this week and 322% YTD. About a year and a half ago, we called out Navitas Semiconductor (NASDAQ:NVTS) as a penny stock to watch, saying it could more than double in ...

GAITHERSBURG, MARYLAND / ACCESS Newswire / October 2, 2025 / Navitas Life Sciences, a global CRO delivering end-to-end solutions across clinical, regulatory, and safety operations, today announced ...